Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT06896188 |
Title | 9-ING-41 Combined with Retifanlimab, Plus Modified FOLFIRINOX for Patients with Advanced Pancreatic Adenocarcinoma (RiLEY) (RiLEY) |
Acronym | RiLEY |
Recruitment | Not yet recruiting |
Gender | both |
Phase | Phase I |
Variant Requirements | No |
Sponsors | Anwaar Saeed |
Indications | |
Therapies | |
Age Groups: | senior | adult |
Covered Countries | USA |